Industry News

2014 MichBio Expo & Conference includes appearances by Congressman John Dingell, Senator Debbie Stabenow, and U.S. FDA Commissioner Margaret A. Hamburg, MD
Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Three Lots of Ketorolac Tromethamine Injection, USP, 30mg/mL Due to Labeling the Product With the Incorrect Expiration Date
US Patent Office Institutes Inter Partes Review Brought by MonoSol Rx Against All Claims in Key BDSI BEMA Patent
Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Three Lots of Ketorolac Tromethamine Injection, USP, 30mg/ml Due to Labeling the...
TraceLink Ensures DSCSA Compliance Across Pharma Supply Chain With Enhanced Product Track Solution
Thai scientists discover antibody to cure Ebola
TraceLink Ensures DSCSA Compliance Across Pharma Supply Chain With Enhanced Product Track Solution
Sanofi Pasteur Introduces 4-Strain Influenza Vaccine in Canada
Merck Completes Sale of Consumer Care Business to Bayer AG for $14.2 Billion
Sanofi Pasteur Introduces 4-Strain Influenza Vaccine in Canada
Thai scientists discover antibody to cure Ebola
Bar coding earning its stripes in middle age
2014 Career & Salary Survey: IN CHECK
Thinking outside the box about inside the box
Baxter to Form New Global Innovation and R&D Center near Boston for Its Biopharmaceuticals Business
Baxter to Form New Global Innovation and R&D Center near Boston for Its Biopharmaceuticals Business
MesotheliomaHelp.org Reacts to FDA's Approval of Keytruda Cancer Drug
Intuitive Surgical Receives FDA Clearance for First Single-Site(R) Wristed Needle Driver for da Vinci(R) Si(R) Surgical System
FDA Approves NeuroGenetic Pharmaceuticals Application to Begin Clinical Trials for Its NGP 555 Compound to Treat and Prevent Alzheimer�s Disease
First Patients Enrolled in Landmark Clinical Study to Evaluate the Role of Packaging in Improving Medication Adherence
Horizon Discovery To Buy Sage Labs For Up To USD48 Million
Allergan Announces FDA Approves Revised Indication for OZURDEX� (dexamethasone intravitreal implant) 0.7 mg for the Treatment of Diabetic Macular Edema
First Patients Enrolled in Landmark Clinical Study to Evaluate the Role of Packaging in Improving Medication Adherence
Intuitive Surgical Receives FDA Clearance for First Single-Site(R) Wristed Needle Driver for da Vinci(R) Si(R) Surgical System
Allergan Announces FDA Approves Revised Indication for OZURDEX� (dexamethasone intravitreal implant) 0.7 mg for the Treatment of Diabetic Macular Edema